RxDoctor Payments Data

Santiago Lopez

Pediatric Infectious Diseases · Sioux Falls, SDNPI 1922351246

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $8,130 of the $12,431 with a category attached, or 65.4%. Merck accounts for 67.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $8,858 and has fallen 99.3% since, to $60 in 2025.

$12,431in general payments, 2019–2025

Across 16 payments — averaging $776.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$8K
  • Seqirus USA Inc$4K
  • Pfizer$60
  • Novo Nordisk$14
  • Amgen$13
$600,615in research payments, 2019–2025

Across 138 payments — averaging $4352.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$562K
  • GSK$19K
  • Astrazeneca UK Limited$11K
  • Modernatx, Inc.$5K
  • Merck$3K

What the payments were for

  • Speaking & faculty fees$4,00032%
  • Travel & lodging$8,13065%
  • Food & beverage$2882%
  • Education$130%

General payments by program year

20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck10$8,345
Seqirus USA Inc3$4,000
Pfizer1$60
Novo Nordisk1$14
Amgen1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric infectious diseases providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Other pediatric infectious diseases in Sioux Falls

Where these figures come from

Is this you, or does something look wrong? →